Pharmacy World Congress coming to Brisbane in 2021

September 1, 2018

PSA, on behalf of the Australian member organisations of the International Pharmaceutical Federation (FIP), is proud to announce Brisbane will host the FIP World Congress of Pharmacy and Pharmaceutical Sciences in 2021.

 

The International Pharmaceutical Federation (FIP) is the global body representing pharmacy and pharmaceutical sciences.

 

As the peak national body for all pharmacists, PSA, in collaboration with the Society of Hospital Pharmacists of Australia (SHPA) and the Australasian Pharmaceutical Science Association (APSA) won a consortium bid to host the major international event at the Brisbane Convention & Exhibition Centre.

 

PSA National President Dr Shane Jackson said the FIP Congress 2021 will provide a platform to showcase global innovation, including models that support pharmacists practising to their full scope, and the health outcomes that these models have delivered in other countries.

 

“The FIP Congress 2021 is a landmark opportunity to continue to ensure roles, recognition and remuneration for pharmacists in Australia are optimised and comparable with other countries around the world.

 

“PSA is leading the profession by bringing Australian pharmacy practice to the world stage.”

 

PSA will draw on its experience delivering its flagship annual conference PSA18, which this year attracted more than 1,000 delegates and received overwhelmingly positive feedback.

 

Combined, the host organisations represent over 20,000 members across Australia in community and hospital pharmacy, academia and the pharmaceutical sciences.

 

The Consortium’s bid is strongly supported by the two New Zealand FIP member organisations – the Pharmaceutical Society of New Zealand (PSNZ) and the New Zealand Hospital Pharmacists Association (NHPA) – as well as the FIP Western Pacific Pharmaceutical Forum, which will help spread the message to the Asia Pacific region.

-ENDS-

Jarryd Luke
Senior Communications Officer
0487 922 176

Ben Coghlan wins 2018 Pharmacy Student of the Year Award

July 28, 2018

 

Ben Coghlan from the ACT has won both the 2018 PSA Pharmacy Student of the Year (PSOTY) Award and the People’s Choice Award, announced at the PSA18 Gala Dinner in Sydney tonight.

 

PSA National President Dr Shane Jackson congratulated Mr Coghlan on his exceptional achievement

 

“The PSOTY Award gives outstanding pharmacy students the chance to showcase their counselling skills to their peers and the wider profession,” Dr Jackson said.

 

“We saw many rising stars of pharmacy apply their clinical knowledge and communication skills in this year’s competition.”

 

The judges were impressed by the strong field of State, Territory and wildcard finalists:

 

  • Vanessa Koumi, University of South Australia (SA/NT)
  • Rhiannon Froude, Monash University (VIC)
  • Irini Moutsatsos, University of Tasmania (TAS)
  • Stephanie Figgins, Griffith University (QLD)
  • Ben Coghlan, University of Canberra (ACT)
  • Charlotte Earl, Curtin University of Technology (WA)
  • Katherine Pollard, University of New England (NSW)
  • NAPSA Wildcard – Gabrielle Wilson, La Trobe University (VIC)

This year’s competition was sponsored by Mylan.

 

The winner receives the National Travel Prize for pharmacy-specific education of an expenses-paid trip to an international pharmacy conference.

 

Mylan Strategic Program Lead Charbel Azzi said: “Mylan would like to congratulate Mr Coghlan on his outstanding achievement. All the finalists displayed well-rounded knowledge and the ability to apply it in a tightly fought competition.

 

“It fills me with confidence and reassurance to know the future of the profession and the industry will be in great hands. As a company whose mission is focused on creating better health, Mylan is deeply committed to supporting programs that inspire future scientists, pharmacists and physicians.”

 

“PSA thanks Mylan for their fantastic support of this award,” Dr Jackson said.

 

-ENDS-

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

Pharmacists and GPs must work together for the best patient outcomes

July 2, 2018

As long as there is a turf war over who delivers patient care, patients will suffer, PSA said today.

 

The RACGP’s attack on pharmacy health checks does not take into account the fact that these services are within a pharmacist’s scope of practice and build on the accessibility of the community pharmacy network.

 

As long as the services are delivered according to the pharmacy profession’s standard for screening and risk assessment, PSA as the peak national body for pharmacists supports the provision of these services within community pharmacy.

 

PSA National President Dr Shane Jackson said, “Countless pharmacies across the country have excellent working relationships with their local GPs.

 

“As readily accessible healthcare professionals, pharmacists are many patients’ first port of call. Pharmacists use health checks to refer patients who are potentially at risk to a GP, when those patients might otherwise avoid or delay doing so.”

 

Dr Jackson said the Coroner’s Findings from the recent inquest into the death of a Victorian patient demonstrated the importance of the relationship between doctors and pharmacists.

 

According to the coroner, “Doctors and pharmacists should trust and respect each other, whilst retaining their independence.

 

“Similarly, whilst pharmacists should respect the doctor-patient relationship, they should not underestimate their own importance in the delivery of health care.”

 

Dr Jackson said, “We cannot afford to ignore this call for GPs and pharmacists to continue building respectful working relationships.

 

“We urge the RACGP to put aside such misdirected professional rivalries and focus on collaborating to improve Australia’s health.”

 

-ENDS-

 

Media contact:           
Jarryd Luke
Communications Officer
0487 922 176

Pharmacy Shark Tank finalists to take the plunge

July 2, 2018

PSA has announced the three finalists who will pitch their innovative pharmacy idea or product to the Pharmacy Shark Tank at PSA18 for a chance to share in a $10,000 prize pool.

 

Pharmacists and researchers from across the country submitted applications for the Pharmacy Shark Tank, but only three will face the sharks in front of a live audience:

  • Professor Lyndal Trevena (NSW), representing a team of researchers from Sydney whose innovation will potentially eliminate future medicine dose errors
  • Michelle Cassumbhoy MPS and Carson Au MPS (VIC), whose unique product aims to help cancer patients undergoing radiation therapy
  • Samuel Keitaanpaa MPS (NT), whose innovation tackles medicine supply issues.

 

After the finalists have presented their case and fielded questions from the sharks and audience, each shark will reveal which idea they’ve chosen to invest in.

 

The crowd favourite will also be granted the People’s Choice Award.

 

The winners can use their prize money to bring their groundbreaking ideas to life.

 

Representing the cutting edge of the industry, the sharks include a pharmacy thought leader and researcher, a strategist, and a healthcare innovator and influencer.

 

Delegates can watch the action as the finalists walk the plank at the Pharmacy Shark Tank Session at PSA18 on Friday 27 July at 2.00 – 3.30 pm.

 

PSA18 is the flagship conference of the Pharmaceutical Society of Australia, the peak national body for pharmacists.

 

The conference will take place from 27 to 29 July 2018 at the Hyatt Regency Sydney.

 

Register now at www.PSA18.com

 

-ENDS-

 

Media contact: 
Jarryd Luke
PSA Communications Officer
0487 922 176